Bericht
Analysis of COVID-related patents for antibodies and vaccines
This paper provides an analysis of patents covering selected antibodies and vaccines used in the treatment or prevention of COVID-19. The aim of the report is to support national patent offices and interested parties in developing countries with information that can serve as guidance for the examination of the claims contained in relevant patents or patent applications. The antibody combination considered for the patent analysis in this paper are Casirivimab and Imdevimab. The vaccines considered for the patent analysis are mRNA-1273, Sputnik, ChAdOx1 nCoV-19 vaccine (AZD1222). The analysis was completed in May 2022.
- Language
-
Englisch
- Bibliographic citation
-
Series: Research Paper ; No. 173
- Classification
-
Sozialwissenschaften, Soziologie, Anthropologie
- Subject
-
Access to Medicines
Antibodies
COVID-19
Global Health
Health
Intellectual Property
Pandemic
Patent
Patent Examination
Patent Law
Patent Offices
Patent Policy
Patent Protection
Public Health
Vaccines
- Event
-
Geistige Schöpfung
- (who)
-
Santhanam, Kausalya
- Event
-
Veröffentlichung
- (who)
-
South Centre
- (where)
-
Geneva
- (when)
-
2023
- Handle
- Last update
-
10.03.2025, 11:45 AM CET
Data provider
This object is provided by:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. If you have any questions about the object, please contact the data provider.
Object type
- Bericht
Associated
- Santhanam, Kausalya
- South Centre
Time of origin
- 2023
Other Objects (12)
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
Equitable access to COVID-19 related health technologies: A global priority
COVID-19 vaccines as global public goods: Between life and profit
The WTO TRIPS decision on COVID-19 vaccines: What is needed to implement it?
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The World Health Organization reforms in the time of COVID-19
Re-thinking global and local manufacturing of medical products after COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales
A response to COVID-19 and beyond: Expanding African capacity in vaccine production
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
Equitable access to COVID-19 related health technologies: A global priority
COVID-19 vaccines as global public goods: Between life and profit
The WTO TRIPS decision on COVID-19 vaccines: What is needed to implement it?
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The World Health Organization reforms in the time of COVID-19
Re-thinking global and local manufacturing of medical products after COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales
A response to COVID-19 and beyond: Expanding African capacity in vaccine production
The TRIPS waiver proposal: An urgent measure to expand access to the COVID-19 vaccines
Equitable access to COVID-19 related health technologies: A global priority
COVID-19 vaccines as global public goods: Between life and profit
The WTO TRIPS decision on COVID-19 vaccines: What is needed to implement it?
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The World Health Organization reforms in the time of COVID-19
Re-thinking global and local manufacturing of medical products after COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 pandemic
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Del SIDA al COVID-19: La OMS ante las crisis sanitarias globales